LEADER 01804nam  2200373   450 
001 9910688180903321
005 20230625102922.0
035   $a(CKB)5580000000514300
035   $a(NjHacI)995580000000514300
035   $a(EXLCZ)995580000000514300
100   $a20230625d2022      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aCOVID-19, Neuroimmunology and Neural Function /$fedited by Thomas Heinbockel and Robert Weissert
210  1$aLondon, United Kingdom :$cIntechOpen,$d2022.
215   $a1 online resource (134 pages) $cillustrations
311   $a1-80355-032-5 
330   $aThe recent and ongoing COVID-19 pandemic has changed societies and research around the world. As such, this new book examines the latest developments in the field of neuroscience related to these changes. It includes six chapters in two sections: "COVID-19 Effects: Neurology, Neuroimmunology, Neurogenesis" and "Molecular and Cellular Neurochemistry." The first section includes chapters that address such topics as COVID's effect on adult neurogenesis, neurological manifestations of COVID-19, and COVID-19 and seizures. Chapters in the second section discuss peripheral biomarkers in multiple sclerosis, amino acids as neurotransmitters, advancements in RNA sequencing technologies, and more.
606   $aCOVID-19 (Disease)
606   $aNeuroimmunology
615  0$aCOVID-19 (Disease)
615  0$aNeuroimmunology.
676   $a614.592414
702   $aHeinbockel$b Thomas
702   $aWeissert$b Robert
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910688180903321
996   $aCOVID-19, Neuroimmunology and Neural Function$93136000
997   $aUNINA